Cadila Healthcare gets OAI letter from USFDA for Moraiya facility Medical Dialogues Bureau8 Aug 2019 10:00 AM ISTThe company has received a letter from the USFDA classifying the inspection conducted at its Moraiya facility from April 22 to May 3 as OAI, Cadila...
GSK ends Ebola vaccine RnD; transfers license to US institute Medical Dialogues Bureau8 Aug 2019 9:30 AM ISTGSK had put its Ebola vaccine work on hold after it was unable to progress the product through the final stage, or Phase III, clinical trials toward...
Paras Healthcare appoints Max Healthcare ex-GM Puneet Srivastava as Vice President Farhat Nasim8 Aug 2019 9:00 AM ISTPuneet Srivastava will lead the Sales and Marketing function at a group level. Prior to joining Paras Healthcare, Srivastava was associated with the...
Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets Medical Dialogues Bureau7 Aug 2019 9:30 AM ISTAmphetamine Sulfate tablets is a generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength, it added.New Delhi: Drug firm...
Zydus Cadila completes phase III trial of Diabetes drug Lipaglyn in India Medical Dialogues Bureau5 Aug 2019 10:00 AM ISTSaroglitazar Magnesium was launched in India during September 2013, under the brand name 'Lipaglyn', for the treatment of hypertriglyceridemia and...
Lupin gets EIR from USFDA for Oral Dosage facility in Aurangabad Medical Dialogues Bureau5 Aug 2019 9:45 AM ISTLupin Ltd's Aurangabad facility is involved in the manufacture of Oral Solid Dosage, Oral Liquid and Powder for Oral Suspension products for the US...
Sun Pharma sudden closure of Vadodara RnD units leaves around 85 employees in lurch Farhat Nasim3 Aug 2019 3:26 PM ISTMumbai: In a move that will axe job of around 85 employees (as pegged my market sources), Dilip Shanghvi led Sun Pharmaceuticals Ltd. (Sun Pharma) has...
Zydus Cadila wins USFDA nod for Minocycline Hydrochloride ER tablets to treat acne Medical Dialogues Bureau3 Aug 2019 9:45 AM ISTMinocycline hydrochloride extended-release tablets are indicated to treat only inflammatory lesions of non-modular moderate to severe acne vulgaris in...
Unichem Labs gets 4 USFDA observations for Goa formulation facility Farhat Nasim3 Aug 2019 9:39 AM ISTAt the end of an inspection, the facility received four observations, with no repeat observations and are mostly procedural in nature, Unichem Labs...
Government appoints 108 drug inspectors pan India; Details Farhat Nasim1 Aug 2019 3:43 PM ISTNew Delhi: Through a recent Gazette notification, the Central Government has apprised about the appointment of 108 Inspectors for the country for the...
CDSCO mandates filing of online application for veterinary drugs on new SUGAM portal Farhat Nasim1 Aug 2019 10:57 AM ISTNew Delhi: Through a recent notification, the apex drug regulatory body Central Drugs Standard Control Organization (CDSCO) has informed to file...
Cadila Healthcare Ankleshwar facility successfully completes USFDA inspection Medical Dialogues Bureau1 Aug 2019 9:25 AM IST"The United States Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredient manufacturing facility located at...
